850 related articles for article (PubMed ID: 25869441)
1. Therapeutic targeting of replicative immortality.
Yaswen P; MacKenzie KL; Keith WN; Hentosh P; Rodier F; Zhu J; Firestone GL; Matheu A; Carnero A; Bilsland A; Sundin T; Honoki K; Fujii H; Georgakilas AG; Amedei A; Amin A; Helferich B; Boosani CS; Guha G; Ciriolo MR; Chen S; Mohammed SI; Azmi AS; Bhakta D; Halicka D; Niccolai E; Aquilano K; Ashraf SS; Nowsheen S; Yang X
Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S104-S128. PubMed ID: 25869441
[TBL] [Abstract][Full Text] [Related]
2. Senescence and immortality in hepatocellular carcinoma.
Ozturk M; Arslan-Ergul A; Bagislar S; Senturk S; Yuzugullu H
Cancer Lett; 2009 Dec; 286(1):103-13. PubMed ID: 19070423
[TBL] [Abstract][Full Text] [Related]
3. [Senescence and cellular immortality].
Trentesaux C; Riou JF
Bull Cancer; 2010 Nov; 97(11):1275-83. PubMed ID: 21051314
[TBL] [Abstract][Full Text] [Related]
4. Molecular pathways: harnessing E2F1 regulation for prosenescence therapy in p53-defective cancer cells.
Laine A; Westermarck J
Clin Cancer Res; 2014 Jul; 20(14):3644-50. PubMed ID: 24788101
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming of replicative senescence in hepatocellular carcinoma-derived cells.
Ozturk N; Erdal E; Mumcuoglu M; Akcali KC; Yalcin O; Senturk S; Arslan-Ergul A; Gur B; Yulug I; Cetin-Atalay R; Yakicier C; Yagci T; Tez M; Ozturk M
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2178-83. PubMed ID: 16461895
[TBL] [Abstract][Full Text] [Related]
6. Reduction in mortalin level by its antisense expression causes senescence-like growth arrest in human immortalized cells.
Wadhwa R; Takano S; Taira K; Kaul SC
J Gene Med; 2004 Apr; 6(4):439-44. PubMed ID: 15079818
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence.
Kortlever RM; Higgins PJ; Bernards R
Nat Cell Biol; 2006 Aug; 8(8):877-84. PubMed ID: 16862142
[TBL] [Abstract][Full Text] [Related]
8. Ha-Ras(G12V) induces senescence in primary and immortalized human esophageal keratinocytes with p53 dysfunction.
Takaoka M; Harada H; Deramaudt TB; Oyama K; Andl CD; Johnstone CN; Rhoades B; Enders GH; Opitz OG; Nakagawa H
Oncogene; 2004 Sep; 23(40):6760-8. PubMed ID: 15273725
[TBL] [Abstract][Full Text] [Related]
9. Quantifying replicative senescence as a tumor suppressor pathway and a target for cancer therapy.
Rodriguez-Brenes IA; Wodarz D; Komarova NL
Sci Rep; 2015 Dec; 5():17660. PubMed ID: 26647820
[TBL] [Abstract][Full Text] [Related]
10. Inducing cellular senescence using defined genetic elements.
Nakagawa H; Opitz OG
Methods Mol Biol; 2007; 371():167-78. PubMed ID: 17634581
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity is sufficient to bypass replicative senescence in human limbal and conjunctival but not corneal keratinocytes.
Pellegrini G; Dellambra E; Paterna P; Golisano O; Traverso CE; Rama P; Lacal P; De Luca M
Eur J Cell Biol; 2004 Dec; 83(11-12):691-700. PubMed ID: 15679113
[TBL] [Abstract][Full Text] [Related]
12. Telomerase, checkpoints and cancer.
Harley CB; Sherwood SW
Cancer Surv; 1997; 29():263-84. PubMed ID: 9338104
[TBL] [Abstract][Full Text] [Related]
13. Reversal of human cellular senescence: roles of the p53 and p16 pathways.
Beauséjour CM; Krtolica A; Galimi F; Narita M; Lowe SW; Yaswen P; Campisi J
EMBO J; 2003 Aug; 22(16):4212-22. PubMed ID: 12912919
[TBL] [Abstract][Full Text] [Related]
14. Hallmarks for senescence in carcinogenesis: novel signaling players.
Caino MC; Meshki J; Kazanietz MG
Apoptosis; 2009 Apr; 14(4):392-408. PubMed ID: 19169823
[TBL] [Abstract][Full Text] [Related]
15. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
16. Regulation of replicative and stress-induced senescence by RSK4, which is down-regulated in human tumors.
López-Vicente L; Armengol G; Pons B; Coch L; Argelaguet E; Lleonart M; Hernández-Losa J; de Torres I; Ramon y Cajal S
Clin Cancer Res; 2009 Jul; 15(14):4546-53. PubMed ID: 19584160
[TBL] [Abstract][Full Text] [Related]
17. Cell death during crisis is mediated by mitotic telomere deprotection.
Hayashi MT; Cesare AJ; Rivera T; Karlseder J
Nature; 2015 Jun; 522(7557):492-6. PubMed ID: 26108857
[TBL] [Abstract][Full Text] [Related]
18. Induced senescence in HeLa cervical carcinoma cells containing elevated telomerase activity and extended telomeres.
Goodwin EC; DiMaio D
Cell Growth Differ; 2001 Nov; 12(11):525-34. PubMed ID: 11714633
[TBL] [Abstract][Full Text] [Related]
19. Single-cell analysis of p16(INK4a) and p21(WAF1) expression suggests distinct mechanisms of senescence in normal human and Li-Fraumeni Syndrome fibroblasts.
Mirzayans R; Andrais B; Scott A; Paterson MC; Murray D
J Cell Physiol; 2010 Apr; 223(1):57-67. PubMed ID: 20039273
[TBL] [Abstract][Full Text] [Related]
20. Molecular signaling and genetic pathways of senescence: Its role in tumorigenesis and aging.
Zhang H
J Cell Physiol; 2007 Mar; 210(3):567-74. PubMed ID: 17133363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
